Literature DB >> 22187286

Immunosuppression in sepsis.

Peter A Ward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187286     DOI: 10.1001/jama.2011.1831

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  32 in total

1.  Hospital-based acute care use in survivors of septic shock.

Authors:  Alexandra Ortego; David F Gaieski; Barry D Fuchs; Tiffanie Jones; Scott D Halpern; Dylan S Small; S Cham Sante; Byron Drumheller; Jason D Christie; Mark E Mikkelsen
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

Review 2.  A historical perspective on sepsis.

Authors:  Peter A Ward; Markus Bosmann
Journal:  Am J Pathol       Date:  2012-05-26       Impact factor: 4.307

3.  Mitochondrial Dysfunction, Depleted Purinergic Signaling, and Defective T Cell Vigilance and Immune Defense.

Authors:  Carola Ledderose; Yi Bao; Stephan Ledderose; Tobias Woehrle; Maria Heinisch; Linda Yip; Jingping Zhang; Simon C Robson; Nathan I Shapiro; Wolfgang G Junger
Journal:  J Infect Dis       Date:  2015-07-06       Impact factor: 5.226

4.  Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice.

Authors:  Melissa B McPeak; Dima Youssef; Danielle A Williams; Christopher L Pritchett; Zhi Q Yao; Charles E McCall; Mohamed El Gazzar
Journal:  J Leukoc Biol       Date:  2017-05-05       Impact factor: 4.962

Review 5.  Purinergic Signaling and the Immune Response in Sepsis: A Review.

Authors:  Carola Ledderose; Yi Bao; Yutaka Kondo; Mahtab Fakhari; Christian Slubowski; Jingping Zhang; Wolfgang G Junger
Journal:  Clin Ther       Date:  2016-05-05       Impact factor: 3.393

Review 6.  The inflammatory response in sepsis.

Authors:  Markus Bosmann; Peter A Ward
Journal:  Trends Immunol       Date:  2012-10-02       Impact factor: 16.687

7.  Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis.

Authors:  Georg F Weber; Benjamin G Chousterman; Shun He; Ashley M Fenn; Manfred Nairz; Atsushi Anzai; Thorsten Brenner; Florian Uhle; Yoshiko Iwamoto; Clinton S Robbins; Lorette Noiret; Sarah L Maier; Tina Zönnchen; Nuh N Rahbari; Sebastian Schölch; Anne Klotzsche-von Ameln; Triantafyllos Chavakis; Jürgen Weitz; Stefan Hofer; Markus A Weigand; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

Review 8.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

9.  AMP-Activated Protein Kinase and Glycogen Synthase Kinase 3β Modulate the Severity of Sepsis-Induced Lung Injury.

Authors:  Zhongyu Liu; Nathaniel Bone; Shaoning Jiang; Dae Won Park; Jean-Marc Tadie; Jessy Deshane; Cilina Ann Rodriguez; Jean-Francois Pittet; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2015-11-30       Impact factor: 6.354

Review 10.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.